Pesquisa

Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study

Nikulin I., Bagriy A., Mikhailichenko E., Kutya A., Sovpel Y.

(Rus)

Volume 29, Nº 4 (2022)

Type 3 diabetes mellitus: is there a chance to become famous?

Morgunov L.

(Rus)

Nº 3 (2012)

SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS

Druk I., Nechaeva G., Korennova O., Druk I., Nechayeva G., Korennova O.

Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus

Demidov N.

(Rus)

Volume 28, Nº 4 (2021)

Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus

Chernikova N., Knyshenko O., Ivanova L.

(Rus)

Nº 5 (2015)

Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa

Demidova T.

(Rus)

Nº 5 (2017)

CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Chemikova N.

(Rus)

Volume 27, Nº 4 (2020)

Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?

Abdullaev A., Litvinova D., Rozhkov N., Kiyaev A.

(Rus)

Nº 16 (2010)

SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Mkrtumyan A., Mkrtumyan A.

Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Novikova M., Demidov N.

(Rus)

Nº 16 (2013)

Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov

Ushkalova E.

(Rus)

Nº 5 (2013)

SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA

Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.

(Rus)

Volume 31, Nº 8 (2024)

Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus

Kurnikova I., Chekalina M., Ualikhanova A.

(Rus)

Clinical case of achieving compensation for type 2 diabetes mellitus in preparation for pregnancy in a woman of reproductive age

Markina J.

(Rus)

Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus

Smirnova E.

(Rus)

Volume 30, Nº 3 (2023)

Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination

Biryukova E., Shinkin M., Morozova I.

(Rus)

Volume 29, Nº 4 (2022)

Problem of treatment adherence in patients with type 2 diabetes mellitus

Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.

(Rus)

Combination of two hypoglycemic drugs for type 2 diabetes mellitus

Morgunova T., Fadeyev V.

(Rus)

Volume 26, Nº 14 (2019)

Hypoglycemic drugs and drug-induced heart failure

Ostroumova O., Goloborodova I.

(Rus)

Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus

Izhbuldina G., Novikova L.

(Rus)

Nº 11 (2018)

Problem of detection and pharmacological correction of anxious and depressive disorders in patients with type 2 diabetes mellitus

Sorokina Y., Zanozin A., Zanozina O., Runov G.

(Rus)

Nº 4 (2018)

NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.

(Rus)

Nº 16 (2017)

Fixed-dose combinations in the therapy of type 2 diabetes mellitus: the way to achieving good glycemic control

Biryukova E.

(Rus)

Nº 5 (2016)

POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS

Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.

(Rus)

Nº 17 (2015)

Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa

Antsiferov M., Nikitina T., Rodionova A., Kurbatova K., Ionova T.

(Rus)

Nº 5 (2015)

Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN

Chernikova N., Ivanova L., Abaeva F.

(Rus)

Nº 16 (2014)

Leptin i gormonal'no-metabolicheskie pokazateli u bol'nykh bronkhial'noy astmoy i pri ee sochetanii s sakharnym diabetom 2 tipa

Verbovoy A., Sharonova L., Akhmerova R.

(Rus)

Nº 16 (2013)

Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom

Shavlovskaya O.

(Rus)

Nº 16 (2013)

Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa

Biryukova E., Danilova T.

(Rus)

Nº 5 (2013)

INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY

Antsiferov M., Schemthaner G., Ametov A.

(Rus)

Nº 11 (2012)

Osobennosti lecheniya narusheniy tolerantnosti k glyukoze u patsientov s abdominal'no-vistseral'nym tipom ozhireniya na rannikh etapakh ego razvitiya

Shilov A., Abdullaeva A.

(Rus)

Nº 3 (2012)

GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Antsiferov M., Antsiferov M.

Nº 3 (2011)

RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE

Glinkina I., Romantsova T., Glinkina I., Romantsova T.

Nº 16 (2010)

PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES

Rudakova A., Rudakova A.

Nº 3 (2010)

Advance - movement forward

Petunina N., Petunina N.

Volume 32, Nº 2 (2025)

The impact of disease duration and glycemic control of type 1 diabetes mellitus on the lipid profile and intima-media thickness in children

Sadykova D., Shaydullina M., Aksenova A., Galimova L.

(Rus)

Analysis of the quality of clinical follow-up care of patients with type 2 diabetes mellitus

Demicheva T.

(Rus)

Metabolic effects of metformin in patients with type 2 diabetes mellitus and new coronavirus infection

Zhurtova I., Gubachikova A., Aramisova L., Anaeva L., Abdul Moati H.

(Rus)

The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus

Petrov V., Shatalova O., Klykova M., Stetsky N.

(Rus)

Volume 29, Nº 11/12 (2022)

Place of GLP-1 receptor antagonists and SGLT-2 inhibitors in modern therapy of type 2 diabetes mellitus

Antsiferov M., Koteshkova O., Dukhareva O., Demidov N., Novikova M.

(Rus)

Carbohydrate metabolism disorders and osteoporosis

Alekseeva N.

(Rus)

The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience

Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.

(Rus)

Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)

Demidov N., Mishra O., Antsiferov M.

(Rus)

Nº 4 (2018)

NEW ONCE-WEEKLY GLP-1 RECEPTOR AGONIST - A QUALITATIVE LEAP IN MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Demidova T.

(Rus)

Nº 6 (2017)

POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY

Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.

(Rus)

Nº 5 (2016)

EFFICIENCY OF MULTICOMPONENT THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (CLINICAL CASE)

Koteshkova O., Molina L.

(Rus)

Nº 17 (2015)

10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -

Rybkina I., Petryaykina E., Koltunov I.

(Rus)

Nº 5 (2015)

Alogliptin - effektivnyy i bezopasnyy ingibitor dipeptidilpeptidazy-4 v terapii bol'nykh sakharnym diabetom 2 tipa

Mkrtumyan A.

(Rus)

Nº 16 (2014)

Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa

Biryukova E.

(Rus)

Nº 16 (2013)

Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa

Ametov A., Tertychnaya E.

(Rus)

Nº 5 (2013)

SOSTOYaNIE KOSTNOY TKANI PRI SAKhARNOM DIABETE 2 TIPA

Ruyatkina L., Lomova A., Ruyatkin D.

(Rus)

Nº 3 (2012)

TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS

Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.

Nº 16 (2011)

Galvus and Galvus Met in treatment of elderly patients with type 2 diabetes mellitu

Antsiferov M., Antciferov M.

Nº 3 (2011)

CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS

Antsiferov M., Antsiferov M.

Nº 16 (2010)

ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR

Antsiferov M., Morgunov L., Antsiferov M., Morgunov L.

Nº 8 (2010)

ADIPONECTIN AND C-REACTIVE PROTEIN AS FACTORS OF CARDIOVASCULAR RISK IN MEN WITH TYPE 2 DIABETES MELLITUS

Morkovskikh N., Morkovskikh N.

Nº 3 (2010)

Sulfonylurea drugs and risk of cardiovascular complications - much ado about nothing?

Nedosugova L., Nedosugova L.

Volume 32, Nº 2 (2025)

Efficiency of a fixed combination of insulin glargine and lixisenatide in everyday clinical practice

Elsukova O., Nikitina E.

(Rus)

Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice

Elsukova O., Nikitina E., Chuprova A., Kaysina O.

(Rus)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes mellitus: how to choose the right solution

Antsiferov M., Koteshkova O., Antsiferova D., Demidov N.

(Rus)

Volume 29, Nº 11/12 (2022)

Cardiovascular outcomes during treatment with dipeptidyl peptidase-4 inhibitors depending on renal function and combination with metformin: a systematic review

Petunina N., Martirosyan N., Valeeva F.

(Rus)

Obesity: an invisible disease

Verbovoy A., Dolgikh Y., Verbovaya N., Lomonova T.

(Rus)

Clinical experience of long-term observation of the efficacy of a fixed combination of insulin glargine and GLP-1RA lixisenatide in patients with type 2 diabetes mellitus who did not reach the target glycemia values with the use of oral antidiabetic drugs

Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»

Antsiferov M., Galstyan G.

(Rus)

Volume 27, Nº 4 (2020)

Mkrtumyan A., Markova T.

(Rus)

The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)

Antsiferov M., Kvasnikov B.

(Rus)

Nº 11 (2018)

Apelin: biological and pathophysiological effects

Dolgikh Y., Verbovoy A.

(Rus)

Nº 2 (2018)

Efficiency of different schemes of antihelicbacter therapy in patients with chronic gastroduodenal diseases and type 2 diabetes mellitus

Fedorchenko Y., Martynyuk M.

(Rus)

Nº 6 (2017)

THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS

Shevkunova N.

(Rus)

Nº 5 (2016)

EMPAGLIFLOZIN: ENHANCEMENT OF POTENTIALS OF THE TREATMENT OF TYPE 2 DIABETES MELLITUS

Biryukova E.

(Rus)

Nº 17 (2015)

Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa

Galstyan G.

(Rus)

Nº 5 (2014)

UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa

Antsiferov M., Koteshkova O.

(Rus)

Nº 16 (2013)

Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa

Ametov A.

(Rus)

Nº 10 (2013)

Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa

Demidova I., Boeva V.

(Rus)

Nº 5 (2013)

O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA

Biryukova E.

(Rus)

Nº 3 (2012)

SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS

Nikonova T., Nikonova T.

Nº 16 (2011)

DIPEPTIDYL PEPTIDASE-4 INHIBITORS - NEW POTENTIALS FOR TREATMENT OF TYPE 2 DIABETES MELLITUS: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW

Antsiferov M., Antciferov M.

Nº 3 (2011)

COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Trukhina L., Petunina N., Truhina L.

Nº 16 (2010)

WHEN TO BEGIN COMBINED THERAPY OF TYPE 2 DIABETES MELLITUS

Petunina N., Petunina N.

Nº 3 (2010)

Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)

Antsiferov M., Antsiferov M.

Screening, diagnosis and treatment of early carbohydrate metabolism disorders

Demidova I., Boeva V.

(Rus)

Theory and practice of use of dipeptidyl peptidase-4 inhibitors: focus on evogliptin

Biryukova E.

(Rus)

Volume 29, Nº 11/12 (2022)

Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study

Antsiferov M., Demidov N., Safronova T., Mishra O.

(Rus)

Differentiated approach to metformin therapy in newly diagnosed type 2 diabetes mellitus from the perspective of pharmacogenetics

Shorokhova P., Baranov V.

(Rus)

Vasodilating beta-adrenoceptor blockers in post-myocardial infarction patients with type 2 diabetes

Shchukina E., Gromenkov V., Suprun Y., Mykhailichenko E., Beryozova E., Bagriy V., Golodnikov I.

(Rus)